Treatment adherence and quality of sleep in schizophrenia outpatients

References

• Afonso P, Brissos S, Figueira ML, Paiva T. Schizophrenia patients with predominantly positive symptoms have more disturbed sleep-wake cycles measured by actigraphy. Psychiatry Res 2011;189:62–66.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, 4th ed. (DSM IV-TR); 2000.
   Google Scholar
• Benson KL. Sleep in schizophrenia. Sleep Med Clin 2008;3:251–260.
   Google Scholar
• Bromundt V, Köster M, Georgiev-Kill A, Opwis K, Wirz-Justice A, Stoppe G, Cajochen C. Sleep-wake cycles and cognitive functioning in schizophrenia. Br JPsychiatry 2011;198:269–276.
   PubMed Web of Science ®Google Scholar
• Buisse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
   Google Scholar
• Chemerinski E, Ho B, Flaum M, Arndt S, Fleming F, Andreasen NC. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Compr Psychiatry 2002;43:393–396.
   PubMed Web of Science ®Google Scholar
• Cohrs S, Meier A, Neumann AC, Jordan W, Rüther E, Rodenbeck A. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects. J Clin Psychiatry 2005;66:989–996.
   PubMed Web of Science ®Google Scholar
• Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, Rüther E. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 2004;174:421–429.
   PubMed Web of Science ®Google Scholar
• Cohrs S. Sleep disturbances in patients with schizophrenia: Impact and effect of antipsychotics. CNS Drugs 2008;22:939–962.
   PubMed Web of Science ®Google Scholar
• DeMartinis NA, Winokur A. Effects of psychiatric medications on sleep and sleep disorders. CNS Neurol Disord Drug Targets 2007;6:17–29.
   PubMedGoogle Scholar
• Dencker SJ, Malm U, Lepp M. Schizophrenic relapse after drug withdrawal is predictable. Acta Psychiatr Scand 1986;73:181–185.
   Google Scholar
• Emsley R, Oosthuizen PP, Koen L, Niehaus DJ, Martinez G. Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study. J Clin Psychiatry 2012;73:e541–e547.
   PubMedGoogle Scholar
• Glick ID, Stekoll AH, Hays S. The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia. J Clin Psychopharmacol 2011;31:82–85.
   PubMed Web of Science ®Google Scholar
• Hinze-Selch D, Mullington J, Orth A, Lauer CJ, Pollmächer T. Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry 1997; 42:260–266.
   PubMed Web of Science ®Google Scholar
• Hofstetter JR, Lysaker PH, Mayeda AR. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry 2005;5:13.
   PubMed Web of Science ®Google Scholar
• Kane JM. Utilization of long-acting antipsychotic medication in patient care. CNS Spectr 2006;11:1–7.
   PubMed Web of Science ®Google Scholar
• Kang SG, Lee HJ, Jung SW, Cho SN, Han C, Kim YK, et al. Charac teristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1078–1083.
   PubMed Web of Science ®Google Scholar
• Kato M, Kajimura N, Okuma T, Sekimoto M, Watanabe T, Yamadera H, Takahashi K. Association between delta waves during sleep and negative symptoms in schizophrenia. Pharmaco-eeg studies by using structurally different hypnotics. Neuropsychobiology 1999; 39:165–172.
   Google Scholar
• Keshavan MS, Reynolds CF III, Miewald MJ, Montrose DM, Sweeney JA, Vasko RC Jr, Kupfer DJ. Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data. Arch Gen Psychiatry 1998;55:443–448.
   Google Scholar
• Lee JH, Woo JI, Meltzer HY. Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatry Res 2001;103: 157–166.
   Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al.;Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209–1223.
   PubMed Web of Science ®Google Scholar
• Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, et al. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol 2007;22:299–308.
   PubMed Web of Science ®Google Scholar
• Masand PS, Narasimhan M. Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol 2006;1:47–56.
   PubMedGoogle Scholar
• Masand PS, Roca M, Turner MS, Kane JM. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 2009;11:147–154.
   PubMedGoogle Scholar
• Monti JM, Monti D. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 2004;8:133–148.
   PubMed Web of Science ®Google Scholar
• Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998–2004). Sleep 2006; 29:1398–1414.
   PubMed Web of Science ®Google Scholar
• Müller MJ, Rossbach W, Mann K, Röschke J, Müller-Siecheneder F, Blümler M, et al. Sub chronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms. Pharmacopsychiatry 2004;37:157–162.
   Google Scholar
• National Collaborating Centre for Mental Health commissioned by the National Institute for Health & Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. National Clinical Guideline Number 82. The British Psychological Society & The Royal College of Psychiatrists, 2010.
   Google Scholar
• Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psycho pharmacol Bull 1988;24:97–99.
   Web of Science ®Google Scholar
• Palmese LB, DeGeorge PC, Ratliff JC, Srihari VH, Wexler BE, Krystal AD, Tek C. Insomnia is frequent in schizophrenia and associated with night eating and obesity. Schizophr Res 2011; 133:238–243.
   PubMed Web of Science ®Google Scholar
• Poulin J, Daoust AM, Forest G, Stip E, Godbout R. Sleep architecture and its clinical correlates in first episode and neuroleptic- naive patients with schizophrenia. Schizophr Res 2003;62: 147–153.
   PubMed Web of Science ®Google Scholar
• Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: relationships to sleep quality. Qual Life Res 2004; 13:783–791.
   PubMed Web of Science ®Google Scholar
• Robinson D, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241–247.
   PubMed Web of Science ®Google Scholar
• Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Laurrabaquio MR. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 1999; 46:141–143.
   PubMed Web of Science ®Google Scholar
• San L, Ciudad A, Alvarez E, Gilaberte I. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry 2007;22:490–498.
   PubMed Web of Science ®Google Scholar
• Tandon R, Shipley JE, Taylor S, Greden JF, Eiser A, DeQuardo J, Goodson J. Electroencephalographic sleep abnormalities in schizophrenia: relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry 1992;49:185–194.
   Google Scholar
• Walther S, Koschorke P, Horn H, Strik W. Objectively measured motor activity in schizophrenia challenges the validity of expert ratings. Psychiatry Res 2009;169:187–190.
   PubMedGoogle Scholar
• Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004;55:886–891.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Haug HJ, Cajochen C. Disturbed circadian rest-activity cycles in schizophrenic patients: an effect of drugs?. Schizophrenia Bul 2001;27:497–502.
   PubMed Web of Science ®Google Scholar
• Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry 2012;200:308–316.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Morinobu S, Yamawaki S, Horiguchi J, Nagao M. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res 2002;109:137–142.
   PubMed Web of Science ®Google Scholar